跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
簡 銘賢
教授
,
臨床醫學研究所
合聘教授
,
國際醫學研究碩博士學位學程
成員
,
臺北醫學大學癌症轉譯研究中心
成員
,
臺北醫學大學新藥開發研究中心
https://orcid.org/0000-0002-0084-7231
電子郵件
mhchien1976
gmail
com
No. 250 Wu-Xing Street, Taipei 11031
h-index
5271
引文
42
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2008
2025
每年研究成果
概覽
指紋
網路
專案
(26)
研究成果
(157)
資料集
(13)
類似的個人檔案
(12)
指紋
查看啟用 Ming-Hsien Chien 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Pharmacology, Toxicology and Pharmaceutical Science
Acute Myeloid Leukemia
56%
Acyltransferase
24%
Apigenin
19%
Cancer Growth
30%
Cancer Susceptibility
13%
Caspase
26%
Caspase 8
27%
Cell Adhesion Molecule
13%
Community Acquired Pneumonia
18%
Curcumin
14%
Cyclooxygenase 2
18%
Disintegrin
19%
Drug Resistance
14%
Epidermal Growth Factor Receptor
45%
Gelatinase A
31%
Gelatinase B
39%
Glioblastoma
31%
Head and Neck Cancer
17%
Interleukin 17
16%
Leukemia
22%
Liver Cell Carcinoma
37%
Lung Adenocarcinoma
36%
Lung Cancer
66%
Lymph Node Metastasis
14%
Malignant Neoplasm
91%
Melatonin
24%
Metalloproteinase
19%
Metastasis
52%
microRNA
18%
Mitogen Activated Protein Kinase
32%
Mouth Cancer
71%
Mouth Squamous Cell Carcinoma
56%
Neoplasm
60%
Neutrophil Gelatinase Associated Lipocalin
24%
Non Small Cell Lung Cancer
34%
Nuclear Factor
18%
Osteosarcoma
18%
Penfluridol
31%
Phosphotransferase
47%
Prostate Cancer
37%
Quercetin
18%
Reactive Oxygen Metabolite
31%
Recurrent Disease
14%
Renal Cell Carcinoma
18%
Solid Malignant Neoplasm
13%
STAT3 Protein
13%
Transcription Factor Sp1
13%
Tumor Growth
33%
Vasculotropin C
20%
Western Blot
16%
Medicine and Dentistry
Amino Terminal Sequence
19%
Apigenin
13%
Autophagy
19%
Betel
17%
Cancer Cell
42%
Cancer Susceptibility
43%
Carbonate Dehydratase IX
24%
Carcinogen
27%
Carcinogenesis
21%
Carcinoma Cell
13%
Cell Death
13%
Clear Cell Renal Cell Carcinoma
24%
Community-Acquired Pneumonia
18%
Disintegrin
13%
DNA Polymorphism
48%
Environmental Factor
43%
Epidermal Growth Factor Receptor
21%
Gelatinase B
39%
Genetic Variability
18%
Hepatocellular Carcinoma
37%
Histone Methyltransferase
13%
In Vitro
20%
Interleukin 8
18%
Leukemia Cell
13%
Lung Adenocarcinoma
18%
Lung Cancer
38%
Malignant Neoplasm
34%
Mesenchymal-Epithelial Transition
29%
Metalloproteinase
13%
Metastatic Carcinoma
80%
microRNA
14%
Mitogen-Activated Protein Kinase
26%
Mouth Squamous Cell Carcinoma
66%
Neoplasm
28%
Neutrophil Gelatinase Associated Lipocalin
24%
Non Small Cell Lung Cancer
22%
Nuclear Factor
13%
Oral Cancer
100%
Penfluridol
31%
Phosphotransferase
19%
Programmed Cell Death
47%
Promoter Region
17%
Prostate Cancer
24%
Quercetin
18%
Reactive Oxygen Species
24%
Signal Transduction
17%
Single Nucleotide Polymorphism
23%
Snail
24%
Vasculotropin C
13%
Xenograft
20%
Biochemistry, Genetics and Molecular Biology
Allele
45%
Anticancer
16%
Apigenin
19%
Binding Affinity
14%
Cadherin
19%
Cancer Cell
53%
Cancer Stem Cell
14%
Carbonic Anhydrase
24%
Carcinogenesis
30%
Cell Adhesion Molecule
14%
Cell Invasion
19%
Cell Motility
21%
Cell Proliferation
20%
Disease Free Survival
15%
Disintegrin
20%
DNA Binding
14%
Epidermal Growth Factor Receptor
52%
Gelatinase B
33%
Gene Expression
16%
Gene Polymorphism
67%
Genetic Divergence
40%
Genetic Polymorphism
49%
Genetic Variation
16%
Genotyping
41%
Haplotype
17%
Interleukin 8
18%
Lipocalin-2
31%
Long Non-Coding RNA
24%
Melatonin
19%
Mesenchymal-Epithelial Transition
36%
Metalloprotease Inhibitor
18%
Metalloproteinase
20%
MicroRNA
28%
MMP9
33%
N-Acetyltransferase
18%
N-Terminus
16%
Overall Survival
22%
Phosphotransferase
14%
Piper Betle
17%
Promoter Region
27%
Proteoglycan
20%
RNA
17%
RNA-binding Protein
14%
Single-Nucleotide Polymorphism
53%
STAT3
18%
Tissue Microarray
14%
Tumor Progression
15%
Tumor Volume
17%
Vascular Endothelial Growth Factor C
24%
Wild Type
18%
